Skip to main content
BioArctic logo

BioArctic — Investor Relations & Filings

Ticker · BIOA ISIN · SE0010323311 LEI · 549300Y0OI2WVUNHLC33 ST Professional, scientific and technical activities
Filings indexed 434 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country SE Sweden
Listing ST BIOA

BioArctic is a research-intensive biopharmaceutical company focused on developing disease-modifying treatments, biomarkers, and diagnostics for neurodegenerative diseases. The company's core strategy is based on its proprietary antibody technology, which develops unique treatments that target the misfolded and aggregated proteins considered to be the underlying cause of disorders such as Alzheimer's and Parkinson's disease. Through strategic partnerships with global pharmaceutical companies, BioArctic advances its innovative therapies from research through clinical development and commercialization, aiming to address significant unmet medical needs in neurology.

Recent filings

Filing Released Lang Actions
Leqembi® Iqlik™ PDUFA-datum senarelagt till den 24 augusti i USA
Regulatory Filings
2026-05-08 English
Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.
Regulatory Filings
2026-05-08 English
Årsomsättningen för Leqembi® översteg 500 miljoner euro – andra försäljningsmilstolpen uppnådd
Regulatory Filings
2026-04-29 Swedish
Leqembi® annual sales exceed EUR 500 million – second sales milestone achieved
Regulatory Filings
2026-04-29 English
Försäljningen av Leqembi® uppgick till 26,2 miljarder yen under det första kvartalet 2026
Regulatory Filings
2026-04-29 Swedish
Sales of Leqembi® totaled 26.2 billion yen in the first quarter 2026
Earnings Release Classification · 1% confidence The document is a press release announcing preliminary first quarter 2026 sales figures for Leqembi® and the resulting royalty to BioArctic. It provides key highlights of Q1 results (sales and royalty numbers) without full financial statements or detailed analysis. This matches the definition of an Earnings Release (ER): an initial announcement of quarterly financial results with highlights only. Q1 2026
2026-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.